Stephen Hansen - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Stephen Hansen's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Stephen Hansen
Verified
Director of Biopharma Intelligence, BioCentury
England
Beats
Municipal Bonds , Public Finance , Politics , Public Policy , General News
The list is long.
Content
By Stephen Hansen Verified| BioCentury Verified ARTICLE | Editor's CommentaryDespite the rumors, biotech’s specialist investors aren’t at crisis point By Stephen Hansen, Director of Biopharma IntelligenceRumors are flying about the precarious state of biotech’s specialist investor community. Let me set the record straight,the level of concern among investors is high, but theirsituation is not existential.
By Stephen Hansen Verified| BioCentury Verified DATA GRAPHICS | Data ByteSector leads broader market down as tariff worries persist By Stephen Hansen, Director of Biopharma IntelligenceFollowing a short reprieve on Wednesday, biotech indexes resumed their downward fall, leading the broader markets lower as investors continued to sell off equities amid concerns about President Donald Trump’s tariff policies, including the looming threat of pharma-specific tariffs.
By Stephen Hansen Verified| BioCentury Verified ARTICLE | Editor's CommentaryDespite the rumors, biotech’s specialist investors aren’t at crisis point By Stephen Hansen, Director of Biopharma IntelligenceRumors are flying about the precarious state of biotech’s specialist investor community. Let me set the record straight,the level of concern among investors is high, but theirsituation is not existential.
Company Info
BioCentury
BioCentury Inc. is a biotechnology-focused business intelligence and analytics company based in Redwood City, California. With over 30 years of experience, it specializes in providing strategic insights and data analysis tailored to the biopharma and biotech industries. The company reported a revenue of $16.2 million. BioCentury offers the BCIQ platform, which includes modules for tracking companies, products, and financial data. This platform helps clients identify trends, partnerships, and investment opportunities. Additionally, BioCentury provides analytical content that includes market trend analysis, visual data tools, and expert interviews. The company also facilitates networking through exclusive events and workshops, connecting C-suite executives and investors within the biopharma community.
'+1 650-595-5333
Founded: 1992